SELLAS Life Sciences Group, Inc.
SLS
$1.56
-$0.05-3.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.40M | 13.89M | 21.03M | 9.15M | 18.42M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.20M | 2.51M | 512.00K | 814.00K | 1.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.38M | 2.37M | 2.49M | 2.34M | 1.88M |
| Total Current Assets | 31.97M | 16.33M | 24.04M | 12.30M | 21.50M |
|
|
|||||
| Total Current Assets | 31.97M | 16.33M | 24.04M | 12.30M | 21.50M |
| Net Property, Plant & Equipment | 806.00K | 925.00K | 513.00K | 633.00K | 747.00K |
| Long-term Investments | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M |
| Goodwill | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 263.00K | 266.00K | 43.00K | 270.00K | 272.00K |
| Total Assets | 34.96M | 19.43M | 26.51M | 15.12M | 24.43M |
|
|
|||||
| Total Accounts Payable | 3.76M | 3.50M | 4.55M | 6.33M | 7.41M |
| Total Accrued Expenses | 2.52M | 10.89M | 5.32M | 5.08M | 6.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 561.00K | 544.00K | 576.00K | 531.00K | 488.00K |
| Total Finance Division Other Current Liabilities | 52.00K | 42.00K | 174.00K | 103.00K | 52.00K |
| Total Other Current Liabilities | 52.00K | 42.00K | 174.00K | 103.00K | 52.00K |
| Total Current Liabilities | 6.89M | 9.51M | 10.61M | 12.05M | 14.44M |
|
|
|||||
| Total Current Liabilities | 6.89M | 9.51M | 10.61M | 12.05M | 14.44M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 309.00K | 457.00K | -- | 161.00K | 313.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.20M | 9.97M | 10.61M | 12.21M | 14.75M |
|
|
|||||
| Common Stock & APIC | 281.70M | 257.59M | 257.28M | 237.19M | 236.49M |
| Retained Earnings | -253.94M | -248.13M | -241.39M | -234.28M | -226.81M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 27.76M | 9.47M | 15.89M | 2.91M | 9.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 27.76M | 9.47M | 15.89M | 2.91M | 9.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.76M | 9.47M | 15.89M | 2.91M | 9.68M |
|
|
|||||